Online Inquiry
Cat.#: ASSD-136
| Description | A2A antagonist. Binds irreversibly. Apparent pKi values at A2ARs are 8.27 (after 0.5h) and 8.99 (after 3h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-[[7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino]propylcarbamoyl]benzenesulfonyl fluoride |
| Molecular formula | C18H17FN8O4S |
| PubChem identifier | 145958874 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-228 | ImmunoHistoMount (AC228) | 30 ml | inquiry |
| ASSD-165 | FLUO 3-AM (AC165) | 1 mg | inquiry |
| ASSD-190 | Chrysamine G Disodium Salt (AC190) | 10 mg, 25 mg | inquiry |
| ASSD-147 | Rhodamine phalloidin-TRITC (AC147) | 300 tests, 100μg | inquiry |
| ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
| ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
| ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests | inquiry |
| ASSD-186 | Bromocresol Purple (AC186) | 5 g, 10 g | inquiry |
| ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg | inquiry |
| ASSD-196 | 5-Carboxyfluorescein (AC196) | 100 mg, 250 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.